Publication: Celexocib (200 MG/D) or Diclofenac (100 MG/D) in Osteoarthritis: A Multicentre, Double Blind Trial
| dc.contributor.author | Yazici, H | |
| dc.contributor.author | Ozdemir, O | |
| dc.contributor.author | Kirazli, Y | |
| dc.contributor.author | Ozbek, S | |
| dc.contributor.author | Ozerbil, O | |
| dc.contributor.author | Gur, A | |
| dc.contributor.author | Aral, O | |
| dc.contributor.authorID | Uysal, Fusun Guler/0000-0002-4220-0102 | |
| dc.contributor.authorID | Gur, Ali/0000-0001-9680-6268 | |
| dc.contributor.authorID | gilgil, erdal/0000-0002-2763-6223 | |
| dc.date.accessioned | 2020-06-21T15:44:09Z | |
| dc.date.available | 2020-06-21T15:44:09Z | |
| dc.date.issued | 2003 | |
| dc.department | OMÜ | en_US |
| dc.department-temp | Cerrahpasa Med Fac, Istanbul, Turkey -- OMEGA, Contract Res Org, Istanbul, Turkey -- Ege Univ, Izmir, Turkey -- Cukurova Univ, Adana, Turkey -- Selcuk Univ, Konya, Turkey -- Dicle Univ, Diyarbakir, Turkey -- Firat Univ, Elazig, Turkey | en_US |
| dc.description | Annual European Congress of Rheumatology -- JUN 18, 2003 -- LISBON, PORTUGAL | en_US |
| dc.description.abstract | … | en_US |
| dc.identifier.endpage | 260 | en_US |
| dc.identifier.issn | 0003-4967 | |
| dc.identifier.startpage | 260 | en_US |
| dc.identifier.uri | https://hdl.handle.net/20.500.12712/21786 | |
| dc.identifier.volume | 62 | en_US |
| dc.identifier.wos | WOS:000224551400849 | |
| dc.language.iso | en | en_US |
| dc.publisher | BMJ Publishing Group | en_US |
| dc.relation.journal | Annals of the Rheumatic Diseases | en_US |
| dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
| dc.rights | info:eu-repo/semantics/closedAccess | en_US |
| dc.title | Celexocib (200 MG/D) or Diclofenac (100 MG/D) in Osteoarthritis: A Multicentre, Double Blind Trial | en_US |
| dc.type | Conference Object | en_US |
| dspace.entity.type | Publication |
